FDA inspection
Vitalant: FDA inspection ending Dec 20, 2024
FDA inspection 1257839 · No Action Indicated (NAI) · San Francisco, CA
Key facts
| Inspection ID | 1257839 |
|---|---|
| Firm | Vitalant |
| FEI number | 2973165 |
| Address | 555 Buckingham Way |
| City | San Francisco |
| State | CA |
| ZIP | 94132 |
| Country | United States |
| Fiscal year | 2025 |
| Inspection end date | Dec 20, 2024 |
| Classification | No Action Indicated (NAI) |
| Project area | Blood and Blood Products |
| Product type | Biologics |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data